|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003596,
umls-concept:C0006491,
umls-concept:C0008569,
umls-concept:C0012306,
umls-concept:C0013227,
umls-concept:C0016860,
umls-concept:C0017776,
umls-concept:C0019944,
umls-concept:C0027348,
umls-concept:C0030073,
umls-concept:C0030873,
umls-concept:C0040509,
umls-concept:C0042036,
umls-concept:C0348080,
umls-concept:C0936012,
umls-concept:C0998076,
umls-concept:C1511790,
umls-concept:C1627358,
umls-concept:C2349975
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1982-4-22
|
|
pubmed:abstractText |
We have investigated the action of five sources of beta-glucuronidase enzymes on the hydrolysis of glucuronides of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine. For all glucuronides tested, Patella vulgata beta-glucuronidase yielded the largest thin layer chromatographic (TLC) spots. For oxymorphone, P. vulgata was the only treatment to yield detectable TLC spots under test parameters. For these six drugs, TLC spot size and chromatographic quality were compared between control horses and horses pretreated with furosemide four hours earlier. Furosemide pretreatment produced a statistically significant increase in spot size and was found to enhance chromatogram quality. These findings support previous suggestions that P. vulgata is a superior drug-glucuronide hydrolyzing enzyme. They also support earlier reports that administration of furosemide at four hours pre-race is unlikely to result in significant interference with routine drug testing procedures.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0034-5164
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
27-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6173906-Animals,
pubmed-meshheading:6173906-Apomorphine,
pubmed-meshheading:6173906-Butorphanol,
pubmed-meshheading:6173906-Cattle,
pubmed-meshheading:6173906-Chromatography, Thin Layer,
pubmed-meshheading:6173906-Female,
pubmed-meshheading:6173906-Furosemide,
pubmed-meshheading:6173906-Glucuronidase,
pubmed-meshheading:6173906-Helix (Snails),
pubmed-meshheading:6173906-Horses,
pubmed-meshheading:6173906-Hydrolysis,
pubmed-meshheading:6173906-Hydromorphone,
pubmed-meshheading:6173906-Mollusca,
pubmed-meshheading:6173906-Nalbuphine,
pubmed-meshheading:6173906-Oxymorphone,
pubmed-meshheading:6173906-Pentazocine,
pubmed-meshheading:6173906-Species Specificity
|
|
pubmed:year |
1982
|
|
pubmed:articleTitle |
Furosemide, Patella vulgata beta-glucuronidase and drug analysis: conditions for enhancement of the TLC detection of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
